Niki BioSolutions, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate
Niki BioSolutions, Inc. (NIKI) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate of 170.10% for the 12-month period ending 2023-12-31, per its 6-K filed 2025-10-08.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate · last filed 2025-10-08
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 10 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 12 month |
|---|---|---|---|
| 2023-12-31 | 170.10% 6-K · filed 2025-10-08 | ||
| 2022-12-31 | 89.55% 6-K · filed 2025-10-08 | ||
| 2022-06-30 | 89.55% 6-K · filed 2022-09-30 | ||
| 2021-12-31 | 97.70% 20-F · filed 2024-04-30 | ||
| 2021-06-30 | 97.70% 6-K · filed 2022-09-30 | ||
| 2018-12-31 | 58.18% 20-F · filed 2019-04-15 | ||
| 2017-12-31 | 65.70% 20-F · filed 2019-04-15 |